At eight thirty the next morning, I walked into the Dargent Biomedical Investment Committee meeting wearing the same pearl earrings Maud had mocked.

Not out of spite.

I simply refused to let someone else decide what I was allowed to wear in order to be taken seriously.

Twelve people were already seated around the long conference table.

My father, Étienne Dargent, sat at the head.

Rémi Vaudrin was beside him.

Three scientific advisers.

Two independent compliance specialists.

Representatives from our foundation.

And, appearing by video from Valmère University, the vice rector for research and the director of technology transfer.

The three-billion-yuan commitment was the final item on the agenda.

My father opened the file.

“Aveline requested a seventy-two-hour pause.”

Nobody looked surprised.

Everyone knew Cyril and I were together.

That was precisely why I spoke first.

“I want my conflict disclosed formally.”

One committee member nodded.

“Relationship with Professor Cyril Montreux?”

“Yes.”

“Do you recommend cancellation?”

“No.”

That got their attention.

I continued.

“I recommend that my personal relationship with Professor Montreux be treated as irrelevant. The question is whether ORPHEA has governance problems serious enough to make a three-billion-yuan deployment unsafe.”

My father said nothing.

But I could tell he approved.

Not because I was attacking Cyril.

Because I wasn’t.

I projected the archived forum posts onto the screen.

First came the insults.

Then the accusations.

Then the sentence claiming I had exchanged financing for intimacy.

The vice rector’s expression became increasingly uncomfortable.

“We have already opened an internal review.”

Rémi spoke.

“After receiving a legal preservation notice, somebody accessed the post from a terminal assigned to the ORPHEA laboratory and added Ms. Dargent’s full identity.”

The room became quiet.

One of the compliance specialists leaned forward.

“After preservation?”

“Yes.”

“That suggests either extraordinary recklessness or an attempt to escalate the allegation.”

“Correct.”

Then I displayed something else.

A project chart.

Not gossip.

Not screenshots.

ORPHEA’s financial structure.

Equipment procurement.

Subcontractors.

Research milestones.

Personnel dependencies.

The scientific advisers began paying much closer attention.

“I reviewed the project again last night,” I said. “The scientific premise remains strong. But one problem appears repeatedly.”

I highlighted several names.

Maud Lenoir was one of them.

“She has influence over junior researchers despite not holding the authority her behavior suggests.”

The vice rector interrupted.

“Ms. Lenoir is Professor Montreux’s doctoral candidate.”

“Then why,” I asked, “is she included in meetings involving recruitment recommendations, access allocation and internal performance discussions?”

Silence.

One adviser turned toward the screen.

“Is that accurate?”

The vice rector hesitated.

“We’ll need to examine it.”

That answer was enough.

My father closed his pen.

“The funds remain paused.”

The vice rector looked alarmed.

“For how long?”

“Until governance, personnel practices and data integrity are independently reviewed.”

He started protesting.

“Professor Montreux’s team is approaching a critical development window.”

My father’s tone stayed calm.

“Then I suggest they cooperate quickly.”

The meeting ended at nine forty-seven.

Cyril called at nine fifty-one.

I let it ring.

Again.

Again.

Then Maud sent me a message.

So this is what rich women do when someone hurts their feelings? Destroy years of science?

I forwarded it directly to Rémi.

Five minutes later, another arrived.

You think money makes you intelligent.

Forwarded.

Then:

Without Cyril, you’re just your father’s surname.

Forwarded.

Rémi replied:

Please stop helping our evidence file.

I laughed for the first time since visiting the laboratory.

At eleven, Cyril came to my apartment.

I didn’t let him inside.

We spoke in the lobby.

His face looked exhausted.

“What did you do?”

Interesting.

Not Are you okay?

Not I saw the posts.

Not I’m sorry.

“What did you do?”

“I disclosed a governance issue.”

“Aveline, this project employs forty-seven people.”

“I know exactly how many people it employs.”

He blinked.

“How?”

That was when I realized how little he knew about me.

Two years together.

He knew which wine I preferred.

Which restaurant I liked.

Which side of the bed I slept on.

But not the fact that I had spent eight months reading every major technical and financial document associated with the most important project of his career.

“I was part of the investment review.”

His face went completely still.

“What?”

“My family’s biomedical vehicle is one of the proposed lead funders.”

Cyril stared at me.

“You?”

“Yes.”

“For how long?”

“From the beginning.”

His expression changed from confusion to disbelief.

Then anger.

“You hid that from me?”

“I disclosed our relationship to the committee and recused myself from decisions directly involving you whenever necessary.”

“That’s not what I’m asking.”

“No. You’re asking why I didn’t tell you I had influence.”

He said nothing.

“Because I wanted to know whether you loved Aveline,” I continued, “or Aveline Dargent with three billion yuan behind her.”

“That’s insulting.”

“So was telling me a laboratory wasn’t my environment.”

He looked away.

“Aveline, yesterday got out of control.”

“No. Yesterday revealed control.”

“What does that mean?”

“Maud humiliated me. You defended her. Then you ordered me to leave.”

“I was trying to prevent a scene.”

“By removing the person being attacked.”

His jaw tightened.

“She’s under enormous pressure.”

“And that explains the fake corruption accusation too?”

He froze.

“You think Maud wrote it?”

“I don’t know yet.”

He answered too quickly.

“She didn’t.”

I looked at him carefully.

“How do you know?”

Cyril realized his mistake.

“Aveline…”

“How do you know?”

He exhaled.

“Maud told me last night that she posted something.”

Something.

“She told you?”

“She was upset.”

“And you didn’t call me.”

“I was trying to contain it internally.”

“Did you tell her to delete it?”

“Yes.”

“When?”

He hesitated.

That hesitation gave me the answer.

“Before or after my full name was added?”

His face changed.

I stepped closer.

“You knew.”

“I didn’t know she would add your name.”

“But you knew she had written the first post.”

He lowered his voice.

“I thought it was stupid gossip that would disappear.”

“And when my lawyer sent the preservation notice?”

“I told her she needed to stop.”

“Yet someone used your laboratory terminal afterward.”

Cyril became defensive.

“Multiple people have access.”

“Then the audit will determine who.”

He grabbed my wrist.

“Aveline, please.”

I pulled away.

“Don’t.”

For the first time, real fear appeared in his eyes.

“If the investment is lost, ORPHEA could be delayed for years.”

“Then perhaps you should have protected the project from the people inside it.”

“You’re punishing the entire team because of Maud.”

“No.”

I looked directly at him.

“I’m investigating whether the person leading a three-billion-yuan scientific project thinks loyalty to one student matters more than institutional integrity.”

His face went pale.

That afternoon, Valmère suspended Maud’s access to the internal forum and several administrative systems pending investigation.

By evening, forensic logs identified the account that created the original thread.

It belonged to Maud.

That part was expected.

The surprise came next.

The second edit—the one adding my full name—had not been made under her account.

It had been made under Cyril’s credentials.

I read Rémi’s message three times.

Then I called him.

“Could his credentials have been stolen?”

“Possible.”

“Do we know the device?”

“Yes.”

“Which one?”

Rémi paused.

“Professor Montreux’s office workstation.”

My stomach dropped.

Cyril called less than ten minutes later.

I answered.

“Aveline, listen before you decide anything.”

I didn’t speak.

“Maud came into my office last night. She was crying. I went to get coffee. She must have used my computer.”

“You left it unlocked?”

“Yes.”

“During an active legal preservation issue?”

Silence.

“You expect a committee to trust you with preclinical data and billions in capital when you can’t secure your own workstation?”

“That’s unfair.”

“No, Cyril. That’s governance.”

The independent investigation lasted eleven days.

Those eleven days dismantled the version of the laboratory Cyril had shown me.

There was excellent science inside ORPHEA.

There were also serious problems.

Junior researchers described Maud insulting colleagues she considered “superficial.”

One woman said Maud mocked her for taking maternity leave.

Another said she had been called “commercial” because she wore makeup during conference presentations.

A postdoctoral fellow produced messages in which Maud implied that women who networked with investors were “selling themselves.”

And repeatedly, when complaints reached Cyril, he minimized them.

She’s intense.

Don’t take it personally.

She’s brilliant.

Science attracts difficult personalities.

The same phrases he had used with me.

I wasn’t special.

I was simply the first woman Maud targeted who happened to sit on the other side of the funding table.

But then investigators uncovered something more serious.

Maud had altered authorship contributions on two internal project reports, minimizing work performed by junior staff.

There were also irregularities in laboratory notebook timestamps.

Nothing yet proved scientific fraud.

But it was enough to require a research-integrity review.

The three-billion-yuan investment remained frozen.

That was when Maud finally stopped insulting me and started begging Cyril to save her.

He tried.

That cost him his position as project director.

The university didn’t fire Cyril.

His scientific record was too strong, and there was no evidence he had fabricated data.

But the oversight committee concluded that he had repeatedly failed to address misconduct, blurred boundaries with a doctoral student, and allowed personal favoritism to compromise management.

He was removed from administrative control of ORPHEA.

When he called me after the decision, his voice sounded hollow.

“You got what you wanted.”

I was standing inside the Dargent offices, reading the recommendation to preserve the core scientific program under new leadership.

“No.”

“What else do you call this?”

“I wanted ORPHEA funded.”

He laughed bitterly.

“After destroying me?”

“You’re still employed.”

“I lost the project.”

“You lost control of the project.”

“That was my life.”

“No, Cyril.”

I closed the report.

“That was everybody’s work. You just became accustomed to thinking it belonged to you.”

He went silent.

Then he asked:

“Was any part of us real?”

It was the first question that hurt.

“Yes.”

“All of it?”

“On my side.”

He exhaled.

“Aveline…”

“But I can’t stay with someone who only respects intelligence after discovering who signs the checks.”

He had no answer.

I ended the relationship that night.

Maud’s disciplinary process lasted longer.

The university terminated her doctoral appointment after the combined findings involving harassment, misuse of internal systems and research-record irregularities.

She appealed.

She lost.

Her last message to me arrived through an unknown number.

Congratulations. The decorative woman won.

I stared at it for a while.

Then replied for the first and only time.

No.

The documentation did.

I blocked her.

Three months later, the investment committee met again.

ORPHEA had a new director.

Professor Samira El-Khoury.

Brilliant.

Uncomfortable with politics.

Almost painfully direct.

She began her presentation by saying:

“I don’t care whether you like my team. I care whether you trust our controls.”

My father almost smiled.

The independent scientific review had confirmed that the central ORPHEA platform remained promising.

The questionable notebook entries were separated from the validated data set.

New authorship rules were established.

Whistleblower procedures were strengthened.

Personnel decisions no longer flowed through a single professor.

When the vote came, I recused myself from the final investment decision because of my prior relationship with Cyril.

I stepped outside.

Twenty minutes later, my father joined me.

“Well?”

I asked.

“The committee approved the first tranche.”

Not three billion immediately.

Funding would be released in stages, tied to scientific and governance milestones.

Exactly as it should have been.

I smiled.

“Good.”

My father studied me.

“You could have killed the project.”

“I know.”

“You didn’t.”

“Science wasn’t the one who insulted me.”

He nodded once.

That was all.

Six months later, I attended the opening of ORPHEA’s new cell-processing facility.

This time, I wore a dark green dress.

High heels.

And the same pearls.

Nobody laughed.

Not because they finally knew my surname.

Because the culture had changed enough that what a woman wore was no longer considered evidence about whether she belonged in the room.

Professor El-Khoury walked beside me through the new facility.

At one point she nodded toward the pearls.

“Those famous earrings?”

I laughed.

“Unfortunately.”

“They caused a three-billion-yuan review.”

“No.”

I looked through the glass wall at the researchers working inside.

“People caused the review.”

“The earrings just happened to be there.”

Across the room, I noticed Cyril.

He was speaking with two researchers.

No title of project director beneath his name anymore.

Just:

Professor Cyril Montreux — Principal Investigator.

He saw me.

For a second, neither of us moved.

Then he walked over.

“You look well.”

“So do you.”

He glanced toward the laboratory.

“Samira is doing a good job.”

“She is.”

A small smile appeared.

“Better than me, probably.”

“That’s a dangerous level of self-awareness.”

He laughed.

Then became serious.

“I owe you an apology.”

“You owed a lot of people apologies.”

“I gave them.”

That surprised me.

He continued.

“I kept telling myself that protecting difficult brilliant people was part of protecting science.”

“And?”

“I was protecting my own comfort.”

I nodded.

That answer was enough.

Not enough to rebuild us.

But enough to let the anger go.

Cyril looked at my earrings.

“I was an idiot.”

“Yes.”

“You could soften that.”

“I could.”

I smiled.

“I’m choosing scientific accuracy.”

For the first time, we both laughed.

Then someone called his name.

He turned to leave.

“Aveline?”

“Yes?”

“I’m glad you didn’t cancel ORPHEA.”

“So am I.”

He walked away.

I remained behind the observation glass, watching technicians prepare a new experiment.

Months earlier, Maud had called me decorative.

Cyril had told me I didn’t belong in their environment.

And for one angry hour, I had possessed enough influence to hurt everything they cared about.

But that had never been power.

Power would have been destroying their work because they humiliated me.

Responsibility was making sure the work survived without allowing the people who abused it to remain protected.

My phone buzzed.

The committee had approved funding for the next ORPHEA milestone.

I looked once more at the laboratory.

Then at my reflection in the glass.

White pearls.

Perfectly visible.

I smiled.

They had been right about one thing.

I had never belonged in that laboratory.

I belonged in the room where people decided whether laboratories like it deserved to be trusted.